MT-125 is a specific and well-tolerated inhibitor of non-muscle myosin IIA (Ki,NMIIA = 2.7 µM) and IIB (EC50 = 1.7 µM). MT-125 can pass through the blood-brain barrier. MT-125 induces ferroptosis and DNA damage by increasing the levels of reactive oxygen species (ROS) within tumor cells. MT-125 can enhance the PDGFR signaling pathway. MT-125 can be used for research on glioblastoma[1].
Molekulargewicht:
393.87
Formel:
C22H20ClN3O2
Target-Kategorie:
Akt,ERK,Ferroptosis,mTOR,Myosin,PDGFR,Reactive Oxygen Species (ROS)
Anwendungsbeschreibung:
MCE Product type: Reference compound1
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten